<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00169039</url>
  </required_header>
  <id_info>
    <org_study_id>R01MH049891</org_study_id>
    <secondary_id>R01MH049891</secondary_id>
    <nct_id>NCT00169039</nct_id>
  </id_info>
  <brief_title>Clozapine Versus Chlorpromazine for Treatment-Unresponsive Schizophrenia</brief_title>
  <official_title>Clozapine Response and Biogenic Amines in Schizophrenia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Harvard Medical School</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Mental Health (NIMH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>Dartmouth-Hitchcock Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Commonwealth Research Center, Massachusetts</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Novartis</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Harvard Medical School</source>
  <brief_summary>
    <textblock>
      This study will examine the physical response to clozapine or chlorpromazine in people with
      schizophrenia that has not improved with treatment.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a longitudinal double-blind 12-week study of the clinical and biochemical response to
      clozapine or chlorpromazine in a group of treatment-refractory schizophrenic patients.

      The study has 4 phases: (1) A recruitment period; (2) a period of discontinuation of
      psychotropic medication; (3) a drug-washout period; and (4) a 12-week double-blind trial of
      clozapine or chlorpromazine.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <start_date>December 1994</start_date>
  <completion_date>February 2002</completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical measures: Brief Psychiatric Rating Scale, Clinical Global Impression, Scale for the Assessment of Negative Symptoms, Simpson-Angus Scale, Abnormal Involuntary Movement Scale and Barnes Akathisia Scale.</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Biological measures: plasma and urinary samples of dopamine, norepinephrine and their metabolites.</measure>
  </secondary_outcome>
  <enrollment>66</enrollment>
  <condition>Schizophrenia</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Clozapine</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Chlorpromazine</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  19-60 years of age

          -  Diagnosis of schizophrenia

          -  BPRS score &gt; 50

          -  Clinical Global Impressions rating &gt; 4

          -  One of the following: BPRS items rated greater than or equal to 4, conceptual
             disorganization, suspiciousness, hallucinations, unusual thought content.

          -  At least 2 six-week trials of different neuroleptics given at a dosage equivalent to
             at least 600 mg per day of chlorpromazine OR at least 1 eight-week trial of a
             neuroleptic given at a dosage equivalent to at least 800 mg per day of chlorpromazine.

          -  The patient (or the patient's authorized legal representative) must understand the
             nature of the study and sign the informed consent.

        Exclusion Criteria:

          -  History of substance dependence within the past 2 months

          -  Major medical problems precluding the use of clozapine

          -  Pregnancy or lactation

          -  A serious suicide/homicide risk
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alan I Green, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Harvard Medical School</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Commonwealth Research Center</name>
      <address>
        <city>Jamaica Plain</city>
        <state>Massachusetts</state>
        <zip>02130</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Green AI, Alam MY, Boshes RA, Waternaux C, Pappalardo KM, Fitzgibbon ME, Tsuang MT, Schildkraut JJ. Haloperidol response and plasma catecholamines and their metabolites. Schizophr Res. 1993 Jun;10(1):33-7.</citation>
    <PMID>8369230</PMID>
  </reference>
  <reference>
    <citation>Green AI, Alam MY, Sobieraj JT, Pappalardo KM, Waternaux C, Salzman C, Schatzberg AF, Schildkraut JJ. Clozapine response and plasma catecholamines and their metabolites. Psychiatry Res. 1993 Feb;46(2):139-49. Review.</citation>
    <PMID>8483973</PMID>
  </reference>
  <verification_date>April 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 10, 2005</study_first_submitted>
  <study_first_submitted_qc>September 10, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 15, 2005</study_first_posted>
  <last_update_submitted>April 6, 2015</last_update_submitted>
  <last_update_submitted_qc>April 6, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 7, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Harvard Medical School</investigator_affiliation>
    <investigator_full_name>AlanGreen</investigator_full_name>
    <investigator_title>Chair, Department of Psychiatry Geisel School of Medicine at Dartmouth</investigator_title>
  </responsible_party>
  <keyword>Clozapine</keyword>
  <keyword>Chlorpromazine</keyword>
  <keyword>Schizophrenia</keyword>
  <keyword>Biochemistry</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Schizophrenia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Clozapine</mesh_term>
    <mesh_term>Chlorpromazine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

